UCL Discovery Stage
UCL home » Library Services » Electronic resources » UCL Discovery Stage

Neuroinflammation and Alzheimer's Disease: A Machine Learning Approach to CSF Proteomics

Gaetani, L; Bellomo, G; Parnetti, L; Blennow, K; Zetterberg, H; Di Filippo, M; (2021) Neuroinflammation and Alzheimer's Disease: A Machine Learning Approach to CSF Proteomics. Cells , 10 (8) , Article 1930. 10.3390/cells10081930. Green open access

[thumbnail of cells-10-01930.pdf]
Preview
Text
cells-10-01930.pdf - Published Version

Download (1MB) | Preview

Abstract

In Alzheimer’s disease (AD), the contribution of pathophysiological mechanisms other than amyloidosis and tauopathy is now widely recognized, although not clearly quantifiable by means of fluid biomarkers. We aimed to identify quantifiable protein biomarkers reflecting neuroinflammation in AD using multiplex proximity extension assay (PEA) testing. Cerebrospinal fluid (CSF) samples from patients with mild cognitive impairment due to AD (AD-MCI) and from controls, i.e., patients with other neurological diseases (OND), were analyzed with the Olink Inflammation PEA biomarker panel. A machine-learning approach was then used to identify biomarkers discriminating AD-MCI (n: 34) from OND (n: 25). On univariate analysis, SIRT2, HGF, MMP-10, and CXCL5 showed high discriminatory performance (AUC 0.809, p = 5.2 × 10−4, AUC 0.802, p = 6.4 × 10−4, AUC 0.793, p = 3.2 × 10−3, AUC 0.761, p = 2.3 × 10−3, respectively), with higher CSF levels in AD-MCI patients as compared to controls. These same proteins were the best contributors to the penalized logistic regression model discriminating AD-MCI from controls (AUC of the model 0.906, p = 2.97 × 10−7). The biological processes regulated by these proteins include astrocyte and microglia activation, amyloid, and tau misfolding modulation, and blood-brain barrier dysfunction. Using a high-throughput multiplex CSF analysis coupled with a machine-learning statistical approach, we identified novel biomarkers reflecting neuroinflammation in AD. Studies confirming these results by means of different assays are needed to validate PEA as a multiplex technique for CSF analysis and biomarker discovery in the field of neurological diseases.

Type: Article
Title: Neuroinflammation and Alzheimer's Disease: A Machine Learning Approach to CSF Proteomics
Open access status: An open access version is available from UCL Discovery
DOI: 10.3390/cells10081930
Publisher version: https://doi.org/10.3390/cells10081930
Language: English
Additional information: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
Keywords: Alzheimer’s disease; CSF biomarkers; proximity extension assay; neuroinflammation; SIRT2; HGF; MMP-10; CXCL5
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neurodegenerative Diseases
URI: https://discovery-pp.ucl.ac.uk/id/eprint/10134069
Downloads since deposit
3,952Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item